Relating Neuroimmune and Neurovascular Alterations During Alzheimer's Disease Progression
Relating Neuroimmune and Neurovascular Alterations During Alzheimer's Disease Progression
批准号:
10443759
负责人:
Mohammad Abbas Yaseen
金额:
$52.24万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2018
资助国家:
美国
项目状态:
已结题
起止时间:
2018-09-01 至 2024-06-30
关键词:
AffectAgeAlzheimer associated neurodegenerationAlzheimer like pathologyAlzheimer&aposs DiseaseAlzheimer&aposs disease diagnosisAlzheimer&aposs disease modelAlzheimer&aposs disease pathologyAnimal ModelAstrocytesBehavioral SymptomsBlood VesselsBlood capillariesBlood flowBrainCSF1R geneCalciumCellsCerebrovascular CirculationCerebrumCharacteristicsChronicClinicalCognitionCognitiveComplexCouplesCustomDeteriorationDevelopmentDiagnosisDisease ProgressionEarly InterventionElderlyEnergy MetabolismExerciseExposure toFunctional disorderHealthcareImpaired cognitionImpairmentIndividualInflammationInflammatoryInflammatory ResponseInterventionInvestigationKnowledgeLipopolysaccharidesLongitudinal StudiesMediatingMemoryMetabolicMetabolismMethodsMicrogliaMicroscopyMitochondriaModelingModernizationMorphologyMusNerve DegenerationNeurobehavioral ManifestationsNeurofibrillary TanglesNeuroimmuneNeuronsOnset of illnessOptical Coherence TomographyOpticsOxygenPathogenesisPathologicPericytesPeriodicityPharmacologyPhasePhysical activityPre-Clinical ModelPrevention therapyProcessResolutionRoleSeveritiesSignal TransductionSymptomsTechniquesTherapeuticTherapeutic EffectToxic effectTransgenic Organismsabeta accumulationabeta depositionabeta oligomerage relatedaging populationastrogliosisbasecerebral oxygenationcerebrovascularclinical prognosiscognitive functiondesigndiagnostic biomarkerenvironmental enrichment for laboratory animalsimprovedin vivoinhibitorinsightmouse modelneuroinflammationneurovascularneurovascular couplingneurovascular unitnovelnovel markerpre-clinicalprospectiveprotective effectresponsetooltreadmilltreatment strategytwo photon microscopyβ-amyloid burden
中文摘要
摘要
这个项目将探讨如何改变神经免疫相互作用,神经血管信号,和大脑
代谢导致阿尔茨海默病(AD)病理学,沿着运动的潜在益处(又名
体力活动)。考虑到临床预后后认知和功能的迅速,积极恶化
以及AD对日益老龄化的人口构成的可怕威胁,目前缺乏治疗技术,
AD发病和进展的早期、强有力的诊断标志物构成了现代诊断的关键挑战。
健康护理除了强烈相关的病理标志,如淀粉样蛋白-β的积累,
低聚物/斑块和神经细胞缠结,AD进展涉及明显的神经炎性
中枢神经系统细胞如小胶质细胞和星形胶质细胞的反应,以及脑血流、能量
代谢和细胞信号传导。据报道,这些过程在首次出现症状前几年就开始了。
认知能力的下降变得明显。因为没有一个单独的临床前AD症状与
认知障碍,解开这些病理改变之间的关系和相互依赖性
为了更好地理解AD复杂的发病机制,需要对复杂的
细胞和血管的相互作用,在临床前模型的活体大脑中具有高空间分辨率。此外,委员会认为,
尽管保护机制尚不清楚,但体力活动显示出减少这种可能性的希望。
和老年受试者中认知损害的严重程度。使用各种定制设计的高级
显微镜方法,我们将探讨,在细胞和微血管水平,如何看似不同的,
神经免疫和脑血管的变化是相互关联的,以及它们如何共同促进
AD临床前小鼠模型中的毁灭性AD相关神经变性。我们还将研究如何
体力活动可以减轻这些神经免疫和神经血管的改变。结果会帮助我们
更详细地了解大脑中随之而来的多方面结构和功能变化,
在临床上可观察到的认知缺陷出现之前的20年,它们将有助于指导新的早期认知缺陷。
干预和治疗策略,以尽量减少AD相关的认知退化。
英文摘要
ABSTRACT
This project will explore how alterations in neuroimmune interactions, neurovascular signaling, and cerebral
metabolism contribute to Alzheimer's disease (AD) pathology, along with the potential benefits of exercise (aka
physical activity). Given the rapid, aggressive deterioration in cognition and function following clinical prognosis
and the dire threat that AD poses to the rising aging population, the current lack of therapeutic techniques and
early, robust diagnostic markers of AD onset and progression constitutes a critical challenge for modern
healthcare. In addition to strongly associated pathological hallmarks such as accumulation of amyloid-β
oligomers/plaques and neurofibrillary tangles, AD progression involves a pronounced neuroinflammatory
response from CNS cells like microglia and astrocytes, as well as impairments to cerebral blood flow, energy
metabolism, and cellular signaling. These processes reportedly initiate several years before the first symptoms
of cognitive decline become evident. Because no individual preclinical AD symptom correlates perfectly with
cognitive impairment, untangling the relationships and interdependencies between these pathological alterations
is necessary to better understand the complex pathogenesis of AD, and it requires characterization of intricate
cellular and vascular interactions with high spatial resolution in living brains of preclinical models. Furthermore,
although the protective mechanisms remain unclear, physical activity shows promise for reducing the likelihood
and severity of cognitive impairment in elderly subjects. Using a broad assortment of custom-designed advanced
microscopy methods, we will explore, at the cellular and microvascular level, how seemingly distinct
neuroimmune and cerebrovascular changes are interrelated and how they collectively contribute to the
devastating AD-related neurodegeneration in preclinical mouse models of AD. We will also investigate how
physical activity can mitigate these neuroimmune and neurovascular alterations. The results will help us
understand in much greater detail the multifaceted structural and functional changes that ensue in the brain over
the ~2 decades before clinically-observable cognitive deficiencies manifest, and they will help guide new early
intervention and treatment strategies to minimize AD-related cognitive degradation.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Exploring preclinical amyloid pathology with optical microscopy
-
批准号:10193586
-
项目类别:
-
资助金额:$32.75万
-
财政年份:2019
-
负责人:Mohammad Abbas Yaseen
-
依托单位:
Relating Neuroimmune and Neurovascular Alterations During Alzheimer's Disease Progression
-
批准号:10227257
-
项目类别:
-
资助金额:$52.89万
-
财政年份:2018
-
负责人:Mohammad Abbas Yaseen
-
依托单位:
In Vivo Imaging Alzheimers Disease Pathology with 2-Photon/Lifetime Microscopy
-
批准号:9150491
-
项目类别:
-
资助金额:$24.9万
-
财政年份:2015
-
负责人:Mohammad Abbas Yaseen
-
依托单位:
In Vivo Imaging Alzheimers Disease Pathology with 2-Photon/Lifetime Microscopy
-
批准号:8510007
-
项目类别:
-
资助金额:$13.72万
-
财政年份:2013
-
负责人:Mohammad Abbas Yaseen
-
依托单位:
In Vivo Imaging Alzheimers Disease Pathology with 2-Photon/Lifetime Microscopy
-
批准号:8665361
-
项目类别:
-
资助金额:$13.72万
-
财政年份:2013
-
负责人:Mohammad Abbas Yaseen
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: